ATE412406T1 - Verwendung eines sphingosin derivats zur behandlung von mikrobiellen infektionen - Google Patents

Verwendung eines sphingosin derivats zur behandlung von mikrobiellen infektionen

Info

Publication number
ATE412406T1
ATE412406T1 AT02793332T AT02793332T ATE412406T1 AT E412406 T1 ATE412406 T1 AT E412406T1 AT 02793332 T AT02793332 T AT 02793332T AT 02793332 T AT02793332 T AT 02793332T AT E412406 T1 ATE412406 T1 AT E412406T1
Authority
AT
Austria
Prior art keywords
sphingosine
sphingosine derivative
treatment
compounds
methods
Prior art date
Application number
AT02793332T
Other languages
English (en)
Inventor
Maurizio Fraziano
Sanjay Garg
Antonio Ciaramella
Giovanni Auricchio
Elisabetta Volpe
Angelo Martino
Morena Baldini
Vito Paolo De
Domenico Galati
Vittorio Colizzi
Original Assignee
Uni Degli Studi Di Roma S Tor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Degli Studi Di Roma S Tor filed Critical Uni Degli Studi Di Roma S Tor
Application granted granted Critical
Publication of ATE412406T1 publication Critical patent/ATE412406T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02793332T 2001-11-21 2002-11-21 Verwendung eines sphingosin derivats zur behandlung von mikrobiellen infektionen ATE412406T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000688 ITRM20010688A1 (it) 2001-11-21 2001-11-21 Composti immunoregolatori.

Publications (1)

Publication Number Publication Date
ATE412406T1 true ATE412406T1 (de) 2008-11-15

Family

ID=11455889

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793332T ATE412406T1 (de) 2001-11-21 2002-11-21 Verwendung eines sphingosin derivats zur behandlung von mikrobiellen infektionen

Country Status (8)

Country Link
US (2) US8377910B2 (de)
EP (1) EP1453494B1 (de)
AT (1) ATE412406T1 (de)
AU (1) AU2002358986A1 (de)
DE (1) DE60229660D1 (de)
IT (1) ITRM20010688A1 (de)
OA (1) OA13138A (de)
WO (1) WO2003045365A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010688A1 (it) * 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
GB0513431D0 (en) * 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses
WO2014061016A1 (en) * 2012-10-15 2014-04-24 Yeda Research And Development Co. Ltd. Use of sphingoid long chain bases and their analogs in treating and preventing bacterial infections
EP3259990A1 (de) * 2016-06-20 2017-12-27 Ceva Sante Animale Verfahren zur bekämpfung von ektoparasiten bei nichtmenschlichen säugern
IL260690A (en) 2018-07-19 2018-12-31 Yeda Res & Dev Sphingosine derivatives and their use against pulmonary bacterial infections

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321287A3 (de) * 1987-12-18 1990-11-22 City of Hope Hemmung de Lipogenese
US5256641A (en) * 1990-11-01 1993-10-26 State Of Oregon Covalent polar lipid-peptide conjugates for immunological targeting
US5260288A (en) * 1992-04-03 1993-11-09 The Biomembrane Institute Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
KR100260110B1 (ko) * 1993-09-09 2000-07-01 라카일레 지. 필리페 담즙으로부터 추출된 면역조절제 조성물
US5430169A (en) * 1994-02-14 1995-07-04 The United States Of America Represented By The Department Of Health And Human Services Method for preparation of sphingoid bases
EP0754053A1 (de) * 1995-02-03 1997-01-22 Korea Institute of Science and Technology Neuartige blutstillende zusammensetzung
ES2210767T3 (es) * 1997-05-02 2004-07-01 Cosmoferm B.V. Composiciones antimicrobianas para uso topico.
CA2206047A1 (en) * 1997-05-23 1998-11-23 Romeo Rang (Deceased) Immunomodulating compositions for the treatment of viral disorders
JPH1180026A (ja) 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
US6239297B1 (en) * 1997-09-11 2001-05-29 Takara Shuzo Co., Ltd. Sphingosine derivatives and medicinal composition
DE19810999A1 (de) 1998-03-13 1999-09-16 Dermapharm Gmbh Verwendung von Sphingosin, Sphingosin-1-Phosphat, Sphingosin-1-Phosphat-Derivaten und/oder deren Gemischen zur Behandlung von entzündlichen Hautkrankheiten
US6248329B1 (en) 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
FR2823117A1 (fr) * 2000-11-14 2002-10-11 Pharmascience Lab Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans
GB0030700D0 (en) * 2000-12-15 2001-01-31 European Molecular Biology Lab Embl Membrane signalling networks
WO2002060405A1 (en) * 2001-01-29 2002-08-08 Cosmoferm B.V. Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative
CA2437358A1 (en) 2001-01-30 2002-08-22 University Of Virginia Patent Foundation Agonists and antagonists of sphingosine-1-phosphate receptors
ITRM20010688A1 (it) * 2001-11-21 2003-05-21 Univ Roma Composti immunoregolatori.
NZ560662A (en) 2002-05-16 2009-09-25 Novartis Ag Use of EDG receptor binding agents in cancer
CN100516024C (zh) 2002-09-13 2009-07-22 诺瓦提斯公司 氨基-丙醇衍生物
CN1708293A (zh) 2002-09-24 2005-12-14 诺瓦提斯公司 治疗脱髓鞘疾病的鞘氨醇－1－磷酸受体激动剂
NL1022443C2 (nl) * 2003-01-20 2004-07-22 Tno Sphingolipiden voor verbetering van de samenstelling van de darmflora.
AU2004247505B2 (en) * 2003-06-18 2010-01-21 Biolab Ltd. Sphingolipids' polyalkylamines conjugates
JP2008504330A (ja) * 2004-06-29 2008-02-14 ヤド テクノロジーズ ゲゼルシャフト ミット ベシュレンクテル ハフツング スフィンゴ脂質由来医薬組成物
GB0513431D0 (en) * 2005-06-30 2005-08-10 Kherion Technology Ltd Prophylactic compositions and uses

Also Published As

Publication number Publication date
US9078907B2 (en) 2015-07-14
ITRM20010688A1 (it) 2003-05-21
EP1453494A2 (de) 2004-09-08
ITRM20010688A0 (it) 2001-11-21
DE60229660D1 (de) 2008-12-11
OA13138A (en) 2006-12-13
AU2002358986A8 (en) 2003-06-10
US20130202648A1 (en) 2013-08-08
WO2003045365A3 (en) 2004-03-25
US8377910B2 (en) 2013-02-19
AU2002358986A1 (en) 2003-06-10
EP1453494B1 (de) 2008-10-29
WO2003045365A2 (en) 2003-06-05
US20050009757A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
ATE396973T1 (de) Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
DE60329316D1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE440132T1 (de) Bacillus subtilis zur verwendung gegen tierische und menschliche krankheitserreger
BR0110975A (pt) Tratamento profilático e terapêutico de doenças infecciosas ou outras doenças com compostos à base de mono- e disacarìdeos
BRPI0412054A (pt) preparação farmacêutica transdérmica
DE60226729D1 (de) Hydroxyalkylaminderivate als beta-secretase-inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
ES2282685T3 (es) Derivados de hidroxietilamina para el tratamiento de la enfermedad de alzheimer.
IS4389A (is) Efni til að auka geymsluþol skrokka sláturdýra
HUP0302384A2 (hu) Sejtek bioenergia metabolizmusában szerepet játszó biokémiai vegyületeket tartalmazó készítmények és alkalmazásuk
ES2132678T3 (es) Sal de nimesulido hidrosoluble y su utilizacion para el tratamiento de las afecciones inflamatorias.
TR200500221T2 (tr) Farmasötik Maddeler Olarak Bisiklik Amino Asitler
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
DE602004017481D1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE495164T1 (de) Thiadiazolderivate zur behandlung neurodegenerativer krankheiten
SE0104199L (sv) Ny produkt
ATE446285T1 (de) Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3- thiosubstituierte indol-2-alkinsäuren
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen
ATE412406T1 (de) Verwendung eines sphingosin derivats zur behandlung von mikrobiellen infektionen
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
ATE267816T1 (de) Tan-1057 derivate
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
HRP20070441T3 (en) Pharmaceutical combination for the treatment of spasticity and/or pain
ATE453386T1 (de) Polyamin-verbindungen zur behandlung von chemokin-rezeptor-vermittelten krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties